GlassScriptPhysician profile
Brittany Johnson
NPI 1558708032
$1,317.56
in general payments reported to CMS, 2019-2025
27 companies · $50.62 in 2025
The $50.62 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $238 · 2021: $170 · 2022: $230 · 2023: $206 · 2024: $139 · 2025: $50.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.97 | 2019-2023 | |
| Hologic Sales and Service, LLC | $145.05 | 2019-2025 | Aptima, Acessa Provu System, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $105.85 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.48 | 2019-2025 | |
| Coopersurgical, INC. | $76.79 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $75.64 | 2021-2024 | |
| Therapeuticsmd, INC. | $58.79 | 2020-2022 | |
| Exeltis, USA INC. | $53.54 | 2020-2022 | |
| Avion Pharmaceuticals | $50.58 | 2019-2021 | |
| Duchesnay USA Incorporated | $41.69 | 2019 | |
| Agile Therapeutics, INC. | $39.19 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $38.06 | 2023 | Myfembree |
| Medicem INC. | $34.51 | 2021 | |
| Amag Pharmaceuticals, INC. | $29.57 | 2019 | |
| Lupin INC. | $25.67 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $23.46 | 2023 | Saffron |
| Novo Nordisk INC | $22.50 | 2024 | Wegovy, Saxenda |
| Meditrina | $20.58 | 2022 | |
| Smith+Nephew, INC. | $19.17 | 2019 | |
| Axonics, INC. | $18.54 | 2023 | Bulkamid, Axonics |
| Myovant Sciences INC. | $17.91 | 2022 | |
| Ethicon US, LLC | $15.34 | 2020 | |
| Exact Sciences Corporation | $13.69 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $13.65 | 2019 | |
| Minerva Surgical, INC | $13.55 | 2023 | |
| Medtronic, INC. | $12.80 | 2023 | Interstim |
| Merck Sharp & Dohme LLC | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.